Cravath represented the underwriters, led by BofA Merrill Lynch, Goldman, Sachs & Co., J.P. Morgan Securities, Citigroup, Deutsche Bank Securities and RBS, in connection with the US$3.5 billion registered debt offering of Johnson & Johnson, a company engaged in the manufacturing and sale of a broad range of products in the healthcare field. The transaction closed on December 5, 2013.
The Cravath team included partner Craig F. Arcella and associates Andy Ham and Thomas K. Wiesner III. Cameron S. Stanton also worked on this matter.
